RecruitingNCT05524298

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma

Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma Treated With Immunotherapy Or Immunochemotherapy And/Or Radiotherapy: An Observational Prospective Study Of The Fondazione Italiana Linfomi

Sponsor

Fondazione Italiana Linfomi - ETS

Enrollment

150 participants

Start Date

Dec 7, 2022

Study Type

OBSERVATIONAL

Conditions

Low Grade Non-Hodgkin's Lymphoma, Adult

Summary

Aims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life).

Eligibility

Min Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how treatment for slow-growing (indolent) B-cell non-Hodgkin lymphoma affects quality of life in elderly patients (age 70 and older), who are often underrepresented in cancer research. **You may be eligible if...** - You are 70 years or older - You have been diagnosed with a slow-growing B-cell lymphoma: follicular lymphoma, marginal zone lymphoma (including MALT lymphoma), splenic marginal zone lymphoma, or lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia - You have not been previously treated for lymphoma - You are about to start treatment for your lymphoma - You have had a comprehensive geriatric assessment at baseline - You can give informed consent **You may NOT be eligible if...** - None (there are no exclusion criteria listed for this study) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(20)

S.C. Ematologia - A.O. SS. Antonio e Biagio e Cesare Arrigo

Alessandria, Alessandria, Italy

Clinica di Ematologia - A.O.U. Ospedali Riuniti

Ancona, Italy, Italy

U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II

Bari, Italy, Italy

Ematologia - ASST Spedali Civili di Brescia

Brescia, Italy, Italy

Ematologia - Ospedale di Castelfranco Veneto

Castelfranco Veneto, Italy, Italy

U.O.C. di Ematologia - Azienda Ospedaliera Universitaria Policlinico - Rodolico S. Marco

Catania, Italy, Italy

Unità funzionale di Ematologia - Azienda Ospedaliera Universitaria Careggi

Florence, Italy, Italy

S.C. Ematologia - Azienda Ospedali Riuniti Papardo-Piemonte

Messina, Italy, Italy

Unitа Linfomi - Dipartimento Oncoematologia, Istituto Scientifico San Raffaele

Milan, Italy, Italy

S.C. Ematologia - ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy, Italy

Ematologia - A.O.U. Policlinico Giaccone

Palermo, Italy, Italy

Divisione di Ematologia - A.O. Ospedali Riuniti Villa Sofia-Cervello

Palermo, Italy, Italy

U.O. Ematologia - Ospedale Guglielmo da Saliceto

Piacenza, Italy, Italy

Ematologia - Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova

Reggio Emilia, Italy, Italy

U.O. di Ematologia - Ospedale degli Infermi di Rimini

Rimini, Italy, Italy

Ematologia,Trapianto cellule staminali, Medicina Trasfusionale e Terapia cellulare -Policlinico Universitario Campus Bio-Medico

Roma, Italy, Italy

U.O.C. Ematologia - A.O.U. Senese

Siena, Italy, Italy

U.O.C. Ematologia - Ospedale di Circolo

Varese, Italy, Italy

Ospedale San Bassiano - AULSS7 Pedemontana - UOC Oncoematologia

Bassano del Grappa, Vicenza, Italy

Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano

Aviano, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05524298

Related Trials

Epcoritamab and Rituximab for First-line Follicular Lymphoma

NCT057836095 locations